Astellas Pharma

ASTAGRAF XL

Manufacturer:

Astellas Pharma

Astagraf Xl HCPCS:

J7508

HCPCS Code Descriptor:

Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg

Category:

J Code

Astagraf Xl NDCs:

00469-0687-73, 00469-0677-73, 00469-0647-73

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Astagraf Xl:

ASTAGRAF XL is an Immunosuppressant drug manufactured by Astellas Pharma and administered via the Oral route of administration. The J Code: J7508 is aligned to the drug ASTAGRAF XL.

ACCESS PRICING AND MORE BY REGISTERING

J7508 Added Date:

January 1, 2014

J7508 Effective Date:

January 1, 2018

J7508 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Astagraf Xl billing and coding information.
Astagraf Xl patient assistance information can be found through Astellas Cares at the URL: https://www.astagrafxl.com/savings-info
ASTAGRAF XL prescribing information can be found at the link below:
Information regarding ASTAGRAF XL’s side effects can be found at MedlinePlus